Benzinga's Volume Movers

Neurocrine Biosciences (NASDAQ: NBIX ) shares moved up 76.95% to $17.27. The volume of Neurocrine Biosciences shares traded was 4406% higher than normal. Neurocrine Biosciences reported positive results of VMAT2 inhibitor NBI-98854 in Kinect 2 study. Epizyme (NASDAQ: EPZM ) shares rose 66.84% to $34.20. The volume of Epizyme